Presentation of VAR2-based immunotherapy at the 9th CDD Conference on Cancer

Co-founder and executive Chairman of the Board of directors, Dr. Mads Daugaard, are to present data on VAR2-based immunotherapy in the context of the cancer microenvironemnt at the 9th CDD Conference on Cancer, taking place in London, September 17-19, 2018. The title of the talk is "Targeting oncofetal glycosaminoglycans in the tumor microenvironment".